BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Celeris Therapeutics

Celeris Therapeutics logo

Founded
2021
Publications
1

Technologies

AI Companies (Drug Discovery) Protein Degraders Startups

Celeris Therapeutics is going to solve the R&D shortcomings as the pioneer in AI-driven PIC (proximity-inducing compounds) design using an innovative closed-loop engine (Celeris One™ platform) to develop new chemical entities (NCEs) that degrade proteins by establishing proximity to endogenous cellular mechanisms. The solutions include machine learning-driven prediction of interactions, generative design, optimization of molecular properties, and automation of laboratory devices.

Become a Member to view additional information about this company

Posts Mentioning This Company

BiopharmaTrend Blog
New Tools, Products and Technologies